reference/3940847

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3940847

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	186
issn	0168-3659
pageRange	174-186
publicationName	Journal of controlled release : official journal of the Controlled Release Society
startingPage	174
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6e6a1576e1dd63880dbb1cc636c5850b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_274a87fdd2d7d6aaba9a3774c9e5d285 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation	Gao W, Yang X, Lin Z, He B, Mei D, Wang D, Zhang H, Zhang H, Dai W, Wang X, Zhang Q. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT. J Control Release. 2017 Sep 10;261():174–86. doi: 10.1016/j.jconrel.2017.06.018. PMID: 28662902.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1834-2060 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2beceeac378b45dade7d1ef6f4495299 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2adaac8786207783b60e0f49b6392195 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0eb6543001599c7f023fa64a3232ef69 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cc762a1020ec837a9837b9688907864 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_390524a6bdb8badba8a1d4a4e4aac16a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c537b3e815dcfcaa222ad79e270106f3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4aff2352c193684c8cee3990e027390 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b888418c3a3e793fd8f49f4d39223006 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5233-3734 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_899a20745b80347046b9fee5d8c391b5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb530bad5ad88764ee0c10914aa739ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1623caf47e55db9460bc34b1c05103de
date	2017-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/28662902 https://doi.org/10.1016/j.jconrel.2017.06.018
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21032 https://portal.issn.org/resource/ISSN/0168-3659
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT
discusses	http://id.nlm.nih.gov/mesh/M0016238 http://id.nlm.nih.gov/mesh/M0016224 http://id.nlm.nih.gov/mesh/M0544116 http://id.nlm.nih.gov/mesh/M0473123 http://id.nlm.nih.gov/mesh/M0024080 http://id.nlm.nih.gov/mesh/M0539373 http://id.nlm.nih.gov/mesh/M0025279 http://id.nlm.nih.gov/mesh/M0015279
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009369Q000188 http://id.nlm.nih.gov/mesh/D057846Q000008 http://id.nlm.nih.gov/mesh/D010455Q000008 http://id.nlm.nih.gov/mesh/D016572Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D051336Q000187 http://id.nlm.nih.gov/mesh/D057846Q000633 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D051336Q000473 http://id.nlm.nih.gov/mesh/D010446Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D054322Q000008 http://id.nlm.nih.gov/mesh/D016503 http://id.nlm.nih.gov/mesh/D061986 http://id.nlm.nih.gov/mesh/D009369Q000378 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D009842Q000633 http://id.nlm.nih.gov/mesh/D008819 http://id.nlm.nih.gov/mesh/D054322Q000633 http://id.nlm.nih.gov/mesh/D010446Q000633 http://id.nlm.nih.gov/mesh/D010455Q000494 http://id.nlm.nih.gov/mesh/D010455Q000493 http://id.nlm.nih.gov/mesh/D009842Q000008 http://id.nlm.nih.gov/mesh/D006367 http://id.nlm.nih.gov/mesh/D016572Q000633 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D023041
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121225388 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284373 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7231 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71306795 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280754 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25201603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73896891 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5458585 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70695823 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24883466 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129009974 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16404350 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6435893 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2909 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID162639143 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71463825 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49867938 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132274082 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497195

Total number of triples: 90.